The purpose of this course is to meet the needs of healthcare professionals seeking a better understanding of the actions, dosages, onset of action, and adverse effects of diabetes medications in order to provide optimal care to their patient population. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.
Upon completion of this course, you should be able to:
1. Outline the epidemiology of diabetes in the United States.
2. Describe normal fuel metabolism and the pathogenesis of type 1 and type 2 diabetes.
3. Analyze the current state of diabetes research.
4. Identify the diagnostic criteria and screening guidelines for diabetes.
5. Discuss the role of sulfonylureas in the treatment of diabetes, including potential side effects.
6. Review the pharmacology of nonsulfonylurea secretagogues.
7. Compare and contrast the alpha-glucosidase inhibitors available for the treatment of diabetes.
8. Describe the role of metformin in diabetes management.
9. Assess the strengths and weaknesses of thiazolidinediones and dipeptidyl peptidase-4 inhibitors to control blood glucose levels.
10. Identify various bolus insulin options, and outline the risk and response to related hyperglycemic crises.
11. Discuss the importance of basal insulin in the treatment of type 1 and type 2 diabetes.
12. Compare the efficacy and actions of incretin mimetics and amylin analogs.
13. Choose key topics that should be included in patient education plans for individuals being treated with oral or injectable diabetes medications.
This 10-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.
